Overview

The OBstetric Lidocaine Patch (OBLido) Trial

Status:
Completed

Trial end date:
2019-11-30

Target enrollment:

Participant gender:

Summary

This study will be a single-center, single blind, randomized controlled trial. The study will be conducted at UnityPoint-Health Meriter Hospital under investigators from the University of Wisconsin-Madison. Obstetric patients with prepregnancy obesity undergoing a Cesarean delivery at UnityPoint-Health Meriter will be eligible.

Phase:

Phase 4

Details

Lead Sponsor:

University of Wisconsin, Madison

Treatments:

Lidocaine